Today

Agents

Chat

Arena

Discover

More

App

Kalaris Therapeutics files Form 3 for CFO Liisa Ann Bayko - KLRS News | Rallies

Kalaris Therapeutics files Form 3 for CFO Liisa Ann Bayko

KLRS•2026-07-20

Form 3 filing names new CFO

Kalaris Therapeutics filed a Form 3 for Liisa Ann Bayko, naming her chief financial officer in an initial insider ownership disclosure dated July 20, 2026.

Related News

Synchrony Financial 2Q’26 net earnings available to common stockholders rise 9% to $946 million

SYF•2026-07-21

Boeing and MSC Air Cargo today announced that the air cargo operator has purchased five 777-8 freighters

BA•2026-07-21

NASDAQ Trade Halt Continues <MAGH.O> Reason Not Available at 03:58 AM

MAGH•2026-07-21

Sources

S

Kalaris Therapeutics files Form 3 for CFO Liisa Ann Bayko

Sec

FedEx opens Košice logistics facility in Slovakia, expanding eastern region network

FDX•2026-07-21

Liberty Latin America To Sell Stake In WOW Tel S.A.C. To America Movil Peru

LILA•2026-07-21